ZBH-2011-02

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameZBH-2011-02
Drug Alias NameResveratrol Derivative (Institute of Pharmacology and Toxicology Academy of Military Medical Sciences)ZBH-2011-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipoprotein lipase stimulantsPeroxisome proliferator activated receptor agonists
TargetsLipoprotein lipasePeroxisome proliferator activated receptor
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesInstitute Of Toxicants And Drugs, Academy Of Military Medical Sciences, Chinese People'S Liberation Army
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitute Of Toxicants And Drugs, Academy Of Military Medical Sciences, Chinese People'S Liberation Army
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A